s6y
Company name or ticker
Search
RECURSION PHARMACEUTICALS, INC.
3
Hallett David: Initial statement of beneficial ownership of securities
Filed
Friday, January 9, 2026
Period
Jan 1, 2026
Accession number
0002006495-26-000008
Documents
FORM 3
3
EX-24.POA
EX-24.POA
On sec.gov
Filing index
All files
Complete submission text
SGML header